Astrana Health Inc.
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Brandon K. Sim
- Full Time Employees
- 3,000
- Sector
- Health services
- Industry
- Services to the health industry
- Address
- 1668 S. Garfield Avenue Alhambra CA United States 91801
- IPO Date
- Apr 9, 1999
- CIK
- 0001083446
- Website
- astranahealth.com
- Similar Companies
- Business
- Astrana Health, Inc. operates as a physician-centric, technology-powered, risk-bearing healthcare management company primarily in the United States. The company delivers an integrated healthcare delivery platform offering a comprehensive spectrum of medical services including primary care; multi-specialty care; immediate care; radiology; laboratory services; and care coordination for patients. It serves a network of primary care physicians, specialist physicians, extenders, hospitalists, and healthcare providers, supporting patients covered by Medicare, Medicaid, private insurance, and uninsured populations. Astrana operates through three segments: Care Partners, which includes value-based care arrangements facilitating provider performance in population health management; Care Delivery, encompassing direct medical services through physician networks; and Care Enablement, which provides technology and administrative support services to healthcare providers. Founded in 1994 and headquartered in Alhambra, California, Astrana Health focuses on delivering high-quality, cost-effective patient-centered care by leveraging proprietary end-to-end technology solutions that enable providers to succeed in value-based care environments. In the last 1-2 years, Astrana Health has undergone significant strategic changes. The company rebranded from Apollo Medical Holdings, Inc. to Astrana Health, Inc. in February 2024 to reflect its expanded scope and technology-driven care model. It entered into key strategic partnerships, such as a nationwide alliance with Elation Health to expand its support infrastructure for primary care physicians. Astrana also acquired Prospect Health System and Collaborative Health Systems to broaden its care delivery network and enhance its integrated healthcare platform. These moves coincide with its focus on scaling AI-enabled healthcare delivery and strengthening leadership to bolster its technology infrastructure. Astrana Health’s latest reported financials for 2024 show robust revenue growth with total revenue exceeding $2 billion, driven mainly by its Care Partners segment. The company continues to advance patient care quality and provider well-being through technology-enhanced services while expanding its presence across U.S. markets. Astrana Health’s industry positioning is within healthcare providers and services, specializing in value-based care models that emphasize risk-sharing, cost-efficiency, and quality outcomes. Its customer base includes healthcare providers, hospitals, physician groups, health plans, and patients with complex chronic conditions, especially within Medicare Advantage and other public and private insurance frameworks. The company’s targeted geographic operations span across the United States. Leadership enhancements in 2025 underscore a strategic emphasis on scaling AI and technology capabilities to sustain market competitiveness and care innovation. This description encompasses Astrana Health’s core activities, detailed product/service offerings, recent corporate developments, and operational context based on the latest publicly available information.
Company News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH
Is It Too Late to Buy Astrana Health Inc (ASTH) After 4.7% Rally? GF Value Says Undervalued
Astrana Health, Inc. Schedules 2026 Third Quarter Financial Results Release and Conference Call
Why Astrana Health, Inc. (ASTH) is Poised to Beat Earnings Estimates Again
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH
Astrana Health, Inc. (NASDAQ:ASTH) Stock Rated “Moderate Buy” by Wall Street Analysts
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH
Head to Head Review: Tenet Healthcare (NYSE:THC) and Astrana Health (NASDAQ:ASTH)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc. - ASTH
ASTH Investors Have Opportunity to Join Astrana Health, Inc. Fraud Investigation with SBS Law
PRIVACY ALERT: AWKO Law Investigating Astrana Health Data Breach
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH
Lowey Dannenberg, P.C. is Investigating Astrana Health, Inc. (NASDAQ: ASTH) for Potential Violations of the Federal Securities Laws
Astrana Health: 81% Full-Risk And Profitable
Astrana Health, Inc. (ASTH) Q2 2026 Earnings Call Transcript